Hot shot: the wider promise of weight-loss jabs
First they treated diabetes. Then obesity. Now GLP-1 drugs are being tested on a range of other diseases too. Though the US economy is roaring, many Americans are glum about its prospects. How could that affect the election (9:02)? And our podcast on why Chinese migrants are making perilous journeys through the jungle…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
Similar episodes from other shows
More like Economist Podcasts →
The Weight Loss Drug Revolution: Transforming Bodies and Reshaping Economies | The Global Brief
The year of weight-loss drugs
Can weight loss drugs reduce healthcare costs?
Here's How the New Weight Loss Drugs Could Change Everything
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.